JP2023509966A5 - - Google Patents
Info
- Publication number
- JP2023509966A5 JP2023509966A5 JP2022542209A JP2022542209A JP2023509966A5 JP 2023509966 A5 JP2023509966 A5 JP 2023509966A5 JP 2022542209 A JP2022542209 A JP 2022542209A JP 2022542209 A JP2022542209 A JP 2022542209A JP 2023509966 A5 JP2023509966 A5 JP 2023509966A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- composition according
- dna sequence
- dna
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959435P | 2020-01-10 | 2020-01-10 | |
| US62/959,435 | 2020-01-10 | ||
| PCT/US2021/012834 WO2021142366A1 (en) | 2020-01-10 | 2021-01-08 | Compositions and methods of use of oncolytic virus like vesicles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023509966A JP2023509966A (ja) | 2023-03-10 |
| JP2023509966A5 true JP2023509966A5 (https=) | 2024-01-15 |
Family
ID=74595378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542209A Pending JP2023509966A (ja) | 2020-01-10 | 2021-01-08 | 腫瘍溶解性ウイルス様小胞の組成物および使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12577585B2 (https=) |
| EP (1) | EP4087858A1 (https=) |
| JP (1) | JP2023509966A (https=) |
| CN (1) | CN115397838A (https=) |
| WO (1) | WO2021142366A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4460564A4 (en) * | 2022-01-08 | 2026-02-11 | Carogen Corp | MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION |
| JP2025508866A (ja) * | 2022-02-22 | 2025-04-10 | ヴァイロ バイオ インク． | 腫瘍溶解性ウイルスおよび使用方法 |
| CN119110727A (zh) * | 2022-02-22 | 2024-12-10 | 卡罗根公司 | 用于感染性疾病和癌症免疫疗法应用的多功能病毒样囊泡(vlv)平台 |
| US20260034208A1 (en) * | 2022-07-26 | 2026-02-05 | Yale University | Virus-like vesicles (vlvs) based vaccines and methods of preventing, ameliorating, and/or treating covid-19 and/or hepatocellular carcinoma (hcc) |
| IL320318A (en) * | 2022-10-19 | 2025-06-01 | Kalivir Immunotherapeutics Inc | Nucleic acids encoding tgf-beta inhibitor and il-12 and uses thereof |
| WO2024119388A1 (zh) * | 2022-12-07 | 2024-06-13 | 上海鑫湾生物科技有限公司 | 一种用于共表达多种目的基因的构建体及其用途 |
| CN118831091A (zh) * | 2023-04-11 | 2024-10-25 | 浙江自贸区红岸基地生物科技有限公司 | 一种saRNA递送系统及其制备方法和应用 |
| WO2025208054A1 (en) * | 2024-03-28 | 2025-10-02 | Regeneron Pharmaceuticals, Inc. | Recombinant rhabdovirus encoding interleukin-12 (il-12) |
| CN120733012A (zh) * | 2024-08-20 | 2025-10-03 | 浙江大学 | 基于mRNA及蛋白编码的肿瘤药物、制备方法及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1053751A1 (en) * | 1999-05-17 | 2000-11-22 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compositions and methods for treating cell proliferation disorders |
| FR2862982B1 (fr) * | 2003-12-02 | 2006-04-28 | Genethon | Particules virales contenant un vecteur derive d'alpha-virus et procede de preparation de ladite particule virale. |
| ES2746960T3 (es) * | 2006-09-12 | 2020-03-09 | Alphavax Inc | Partículas de replicón de alfavirus que codifican IL-12 como adyuvantes inmunológicos |
| WO2008119827A1 (en) | 2007-04-02 | 2008-10-09 | Fit Biotech Oy | Transreplicase constructs |
| GB2460265A (en) * | 2008-05-23 | 2009-11-25 | Univ Dublin City | Detection assembly |
| AU2015259470A1 (en) | 2014-05-16 | 2016-11-10 | Yale University | Virus like vesicles (VLVs) based vaccines to prevent or treat chronic hepatitis B virus (HBV) infection |
| CN106459997A (zh) * | 2014-05-16 | 2017-02-22 | 耶鲁大学 | 用于疫苗应用的高效价病毒样囊泡的进化 |
| WO2017167317A1 (es) | 2016-03-31 | 2017-10-05 | Centro De Ingenieria Genetica Y Biotecnologia | Composición farmacéutica que comprende los antígenos de la superficie y de la nucleocápsida del virus de la hepatitis b |
| JP2019527737A (ja) * | 2016-08-09 | 2019-10-03 | アルケヤール， アルモハナッドＡＬＫＡＹＹＡＬ， Ａｌｍｏｈａｎａｄ | Ｉｌ１２を発現する腫瘍溶解性ラブドウイルス |
| JP7799945B2 (ja) * | 2017-09-22 | 2026-01-16 | サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィック | 変異型ウイルスタンパク質 |
-
2021
- 2021-01-08 EP EP21705306.5A patent/EP4087858A1/en active Pending
- 2021-01-08 WO PCT/US2021/012834 patent/WO2021142366A1/en not_active Ceased
- 2021-01-08 JP JP2022542209A patent/JP2023509966A/ja active Pending
- 2021-01-08 US US17/791,873 patent/US12577585B2/en active Active
- 2021-01-08 CN CN202180020228.5A patent/CN115397838A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023509966A5 (https=) | ||
| Gardner et al. | Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein | |
| CA2410948C (en) | Method for the purification of alphavirus replicon particles | |
| JP2022191506A5 (https=) | ||
| WO2021189571A1 (zh) | 一种高效诱导机体体液免疫应答的疫苗载体、其制备方法及用途 | |
| CN112584849A (zh) | 包含核酸及car修饰的免疫细胞的治疗剂及其应用 | |
| CN106967685B (zh) | 共表达抗EGFRvIII嵌合抗原受体和免疫检查点抑制分子的转基因淋巴细胞及其用途 | |
| JP2023509966A (ja) | 腫瘍溶解性ウイルス様小胞の組成物および使用方法 | |
| CN108017717A (zh) | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 | |
| Ljungberg et al. | Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine | |
| JP2024073653A (ja) | 遺伝子改変リンパ球の製造方法 | |
| US20240392257A1 (en) | Utilization of Micro-RNA for Downregulation of Cytotoxic Transgene Expression by Modified Vaccinia Virus Ankara (MVA) | |
| CN106459997A (zh) | 用于疫苗应用的高效价病毒样囊泡的进化 | |
| US20260069678A1 (en) | Conjugate polypeptides and vaccines for inducing immune responses | |
| CN110832072A (zh) | 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法 | |
| Zhang et al. | Virus-like vesicles based on Semliki forest virus-containing rabies virus glycoprotein make a safe and efficacious rabies vaccine candidate in a mouse model | |
| Lundstrom | Viral vector-based cancer vaccines | |
| Jeon et al. | Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants | |
| JP2024542126A5 (https=) | ||
| Karlsson et al. | Live viral vectors: Semliki Forest virus | |
| Aranda et al. | A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system | |
| WO2023015276A1 (en) | Adenoviral vector-based vaccine for emerging viruses | |
| Kiener et al. | Efficient delivery of human cytomegalovirus T cell antigens by attenuated Sendai virus vectors | |
| US20240226283A9 (en) | Vaccination of hematopoietic stem cell donors with cytomegalovirus triplex composition | |
| JP2025506732A (ja) | 感染症およびがんの免疫療法適用のための多用途のウイルス様小胞（ｖｌｖ）プラットフォーム |